OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc.

OVIT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.36K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
OncoVista Innovative Therapies, Inc.OncoVista Innovative Therapies, Inc.0-50%--0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2,356.00
Enterprise Value$420,384.00
Earnings per Share$-0.12
Beta-1.04
Outstanding Shares23,054,519

Return

Return on Equity49.63%ROE
Return on Assets-5337.65%
Return on Invested Capital55.27%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.13
Enterprise Value to Net Income-1
Total Debt to Enterprise1.14
Debt to Equity-0.07Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About OncoVista Innovative Therapies, Inc.

2 employees
CEO: Alexander L. Weis

OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies...